This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
17 Jan 2012

India's INMAS Seeks Partners to Commercialise New Drugs and Devices

The institute has developed 30 novel products in the areas of nano-inhalation technology, sublingual injections, treatment of microvasculopathy, gastroenteropathy and emergency medication.

India's Institute of Nuclear Medicines and Allied Sciences (INMAS), a premier life sciences laboratory under the Defence Research and Development Organisation (DRDO), is looking for industry partners for further streamlining of 30 drugs and health products that it has developed.

 

The institute said it has developed 30 novel products that are based on novel concepts in the areas of nano-inhalation technology, sublingual injections, treatment of microvasculopathy, gastroenteropathy and emergency medication.

 

The institute is now seeking joint development partners for scaling up and fine-tuning these to the user requirement and to supply to the defence sector on need basis.

 

The institute also has in

Related News